Trial on pHA130 Hemoadsorption in Kidney Failure Patients Shows Potential for Improved Outcomes
A randomized controlled trial is evaluating the efficacy of the pHA130 hemoadsorption cartridge in enhancing the removal of protein-bound uremic toxins in maintenance hemodialysis patients.